Anti-DNA topoisomerase II α autoantibodies in Japanese patients with systemic sclerosis

Hayakawa, Ikuko; Hasegawa, Minoru; Takehara, Kazuhiko; Sato, Shinichi
October 2005
Archives of Dermatological Research;Oct2005, Vol. 297 Issue 4, p180
Academic Journal
The pathogenesis and etiology of systemic sclerosis (SSc) remain unknown, but the presence of several autoantibodies is recognized as one of its prominent features. The clinical significance of anti-DNA topoisomerase II α antibody (anti-topo II α Ab) remains unknown in Japanese patients with SSc. To determine the prevalence and clinical correlation of anti-topo II α Ab in Japanese patients with SSc. Serum samples were obtained from 103 Japanese patients with SSc. Control serum samples were obtained from 43 healthy Japanese volunteers. Anti-topo II α Abs were determined by enzyme linked-immunosorbent assay.IgG anti-topo II α Ab levels were significantly increased in SSc patients ( n=103) compared to normal controls ( n=43; P<0.005). IgG or IgM anti-topo II α Ab was detected in 19% (20/103) of SSc patients when absorbance values higher than the mean+2SD of control serum samples were considered positive. By contrast, IgG or IgM anti-topo II α Ab was observed in only 7% (3/43) of healthy individuals. The presence of pulmonary fibrosis was more frequently detected in SSc patients with IgG anti-topo II α Ab than those without the Ab ( P<0.05). Moreover, % DLco and % VC were significantly decreased in SSc patients with anti-topo II α Ab relative to those without the Ab ( P<0.05 and P<0.01, respectively). The elevated levels of both erythrocyte sedimentation rate and C-reactive protein were also more frequently observed in SSc patients positive for IgG anti-topo II α Ab ( P<0.005). The results of the present study indicate that anti-topo II α Ab represent one of the autoantibody specificities detected on SSc patients and may be regarded a serological marker of pulmonary fibrosis in Japanese patients with SSc.


Related Articles

  • The Loop Pattern of Chromosomal DNA May Significantly Differ in AT-Rich and GC-Rich Isochores. Svetlova, E. Yu.; Razin, S. V. // Doklady Biochemistry & Biophysics;Mar/Apr2001, Vol. 377 Issue 1-6, p135 

    Discusses a research on the loop pattern of chromosomal DNA that may differ in AT-rich and GC-rich isochores. Differences in the sizes of DNA loops; Feature of a model of DNA organization into loops; Procedure of topoisomerase II-mediated DNA loop excision.

  • Induction of endoreduplication by topoisomerase II catalytic inhibitors. Cortés, Felipe; Pastor, Nuria // Mutagenesis;Mar2003, Vol. 18 Issue 2, p105 

    The striking phenomenon of endoreduplication has long attracted attention from cytogeneticists and researchers into cell cycle enzymology and dynamics alike. Because of the variety of agents able to induce endoreduplication and the various cell types where it has been described, until now no...

  • Lim15/Dmc1 enhances DNA topoisomerase II catenation activity independent of sequence homology. Iwabata, Kazuki; Sakaguchi, Kengo // Chromosoma;Apr2008, Vol. 117 Issue 3, p297 

    We reported previously that Coprinus cinereus Lim15/Dmc1 (CcLim15), a meiosis-specific recA-like protein, could specifically activate C. cinereus DNA topoisomerase II (CcTopII). In particular, it enhanced the catenation activity of CcTopII in vitro at the meiotic prophase stage (Iwabata K,...

  • Differences in the longevity of topo IIα and topo IIβ drug-stabilized cleavable complexes and the relationship to drug sensitivity. Errington, Fiona; Willmore, Elaine; Leontiou, Chrysoula; Tilby, Michael J.; Austin, Caroline A. // Cancer Chemotherapy & Pharmacology;Feb2004, Vol. 53 Issue 2, p155 

    Purpose. DNA topoisomerase II (topo II) is an important cellular target for chemotherapeutic agents. Human cells have two isoforms of topo II (α and β), and both are inhibited by the chemotherapeutic agents etoposide, amsacrine (mAMSA) and mitoxantrone. It is known that the cytotoxic...

  • Epipodophyllotoxins.  // Encyclopedic Reference of Cancer;2001, p295 

    A definition of the term "epipodophyllotoxins" is presented. It refers to compounds or semi-synthetic derivatives of compounds extracted from the mayapple plant. VM-26 and VP-16 are included in this chemical class of compounds and inhibit topoisomerase II.

  • Extracellular matrix alterations and acute inflammation; developing in parallel during early induction of pulmonary fibrosis. Rydell-Törmänen, Kristina; Andréasson, Kristofer; Hesselstrand, Roger; Risteli, Juha; Heinegård, Dick; Saxne, Tore; Westergren-Thorsson, Gunilla // Laboratory Investigation (00236837);Jun2012, Vol. 92 Issue 6, p917 

    Pulmonary fibrosis is a hallmark of several systemic diseases such as systemic sclerosis. Initiation and early development is not well characterized, as initiation usually is unnoticed in patients, yet fibrosis has been considered a late event, occurring after an inflammatory phase. By utilizing...

  • Structure of the topoisomerase VI-B subunit: implications for type II topoisomerase mechanism and evolution. Corbett, Kevin D.; Berger, James M. // EMBO Journal;1/1/2003, Vol. 22 Issue 1, p151 

    Type IIA and type IIB topoisomerases each possess the ability to pass one DNA duplex through another in an ATP-dependent manner. The role of ATP in the strand passage reaction is poorly understood, particularly for the type IIB (topoisomerase VI) family. We have solved the structure of the...

  • PIASy mediates SUMO-2 conjugation of Topoisomerase-II on mitotic chromosomes. Azuma, Yoshiaki; Arnaoutov, Alexei; Anan, Tadashi; Dasso, Mary // EMBO Journal;6/15/2005, Vol. 24 Issue 12, p2172 

    Here we show that the PIASy protein is specifically required for mitotic modification of Topoisomerase-II by SUMO-2 conjugation in Xenopus egg extracts. PIASy was unique among the PIAS family members in its capacity to bind mitotic chromosomes and recruit Ubc9 onto chromatin. These properties...

  • Topoisomerase II, not topoisomerase I, is the proficient relaxase of nucleosomal DNA. Salceda, Javier; Fernández, Xavier; Roca, Joaquim // EMBO Journal;6/7/2006, Vol. 25 Issue 11, p2575 

    Eukaryotic topoisomerases I and II efficiently remove helical tension in naked DNA molecules. However, this activity has not been examined in nucleosomal DNA, their natural substrate. Here, we obtained yeast minichromosomes holding DNA under (+) helical tension, and incubated them with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics